Regional Daily, 14 October 2014 5 Regional Daily Ideas Troika Top Stories Agile Property (3383 HK) Property - Real Estate BUY HKD3.95 TP: HKD4.80 Mkt Cap : USD2,127m Pg2 The government investigation on Agile’s chairman would affect its operations and investor confidence. After the price correction yesterday, we think the valuation is distressed but the bankruptcy risk is low. Maintain BUY and cut TP to HKD4.80. Analyst: John So (john.so@rhbgroup.com) Pg3 Real Estate & Construction Across Malaysia, Singapore & Thailand Other Key Stories Regional Weekly Spices Analyst: Leng Seng Choon CFA (sengchoon.leng@sg.oskgroup.com) Malaysia OldTown (OTB MK) Consumer Cyclical – Retail BUY MYR1.71 TP: MYR2.15 See important disclosures at the end of this report Pg4 Sowing The Seeds Of Long-Term Growth Analyst: Fong Kah Yan (fong.kah.yan@rhbgroup.com) Powered by EFATM Platform 1 Company Update, 14 October 2014 Agile Property (3383 HK) Buy (Maintained) Property - Real Estate Market Cap: USD2,127m Target Price: Price: HKD4.80 HKD3.95 Macro Risks Time Needed To Regain Investor Confidence Growth Value Agile Property Holdings (3383 HK) Price Close Relative to Hang Seng Index (RHS) 10.40 104 9.40 95 8.40 87 7.40 78 6.40 70 5.40 61 4.40 53 3.40 250 44 Aug-14 Jun-14 Dec-13 Feb-14 Apr-14 50 Oct-13 Vol m 100 Source: Bloomberg Avg Turnover (HKD/USD) Cons. Upside (%) Upside (%) 52-wk Price low/high (HKD) Free float (%) Share outstanding (m) Shareholders (%) 68.5m/7.13m 47.6 21.5 3.95 - 9.35 37 4,178 Chan family 63.0 Share Performance (%) YTD 1m 3m 6m 12m Absolute (52.5) (35.5) (29.9) (42.3) (57.7) Relative (53.5) (31.2) (31.2) (44.6) (59.1) Major shareholder to inject cash. Agile Property (Agile) said that a change in chairman would not result in a breach of any of its loan facilities. As at end-June, Agile had CNY13.9bn total cash, including CNY7.7bn in unrestricted cash vs CNY14.5bn in short-term borrowings. Its major shareholder, the Chan family, plans to inject cash to support the company. Note that a major loan is due in 4Q including a CNY2.9bn bridging facility and a CNY2.5bn trust loan and Agile is confident of being able to repay upon maturity. Contracted sales likely to recover in October. Agile announced September contracted sales of CNY2.05bn, a fall of 18% m-o-m and 40% y-o-y. However, its 9M14 contracted sales amounted to CNY28.6bn, a 15% y-o-y rise. Although a change in chairman would affect some business operations, we expect some sales recovery in 4Q14 on better market sentiment. Agile said that its October contracted sales reached CNY2bn in the first 10 days of the month and it sees improvements in the presales of large-sized units. Overall, we estimate FY14 contracted sales at CNY40bn, ie as flat as last year’s. We revise down our FY14/FY15 earnings estimates by 15%/23% respectively to reflect lower contracted sales estimates and higher interest cost. It will take time for investors to regain confidence. Agile should be tight in cash but we believe the bankruptcy risk is low. The incident is expected to hurt investor confidence and affect its normal business operations in the short term. As a result, the company will most probably continue to trade at a bigger valuation discount against peers. Our new TP of HKD4.80 (from HKD7.40), is based on a 65% discount (previously 50%) to its new end-FY14F ENAV of HKD13.80/share (previously HKD14.80/share), which implies a 2SD below 5-year mean. Maintain BUY. Forecasts and Valuations Dec-11 Dec-12 Dec-13 Total turnover (CNYm) 22,944 29,892 35,436 37,012 40,511 Reported net profit (CNYm) 4,105 5,000 4,827 3,865 3,422 Recurring net profit (CNYm) 3,364 4,635 3,843 3,561 3,422 Recurring net profit growth (%) (4.6) 37.8 (17.1) (7.3) (3.9) Recurring EPS (CNY) 0.97 1.34 1.11 1.02 0.98 John So +852 2103 5888 DPS (CNY) 0.28 0.31 0.38 0.19 0.15 john.so@rhbgroup.com Recurring P/E (x) 3.22 2.32 2.80 3.05 3.18 P/B (x) 0.50 0.42 0.37 0.34 0.31 9.0 9.9 12.1 6.2 4.7 20.3 21.1 17.6 12.6 10.2 Dividend Yield (%) Return on average equity (%) Return on average assets (%) Net debt to equity (%) Our vs consensus EPS (adjusted) (%) Dec-14F Dec-15F 5.4 5.8 4.7 3.3 2.8 65.5 64.7 97.6 117.7 110.7 (19.2) (24.7) Source: Company data, RHB See important disclosures at the end of this report 3 . 3 0 . 2 0 0 . 3 0 0 The requirement by the Kunming City People’s Procuratorate for . 0 chairman Chan Zhou Lin to stay at a designated residence since 30 Sep 0 has unavoidably affected Agile’s operations. Yet, while we cut TP by 0 35% to HKD4.80 (from HKD7.40), based on a higher 65% discount to ENAV, we maintain our BUY call. After the price correction, we think the company will most probably continue to trade at a significant valuation discount against peers but the bankruptcy risk is low. 200 150 Powered by EFATM Platform 2 Regional Weekly, 13 October 2014 Weekly Spices Real Estate & Construction Across Malaysia, Singapore & Thailand Quality Houses is a large-cap Thai developer with expected high 2015 earnings growth Source: Bloomberg Gamuda will benefit from the large scale Malaysian infrastructure projects Source: Bloomberg Leng Seng Choon, CFA +65 6232 3890 sengchoon.leng@sg.oskgroup.com Hong Kong Research Indonesia Research Malaysia Research Singapore Research Thailand Research See important disclosures at the end of this report We like Thailand’s real estate sector and expect double-digit 2015 presales. The S-REITs space could see more pros from the MAS’ recent paper and the Malaysian Budget, announced last Friday, points to gains for the construction sector. Homebuyer sentiment in Thailand, which has improved since May, boosted q-o-q presales of the seven major listed developers by 58% in 2Q14 and 9% in 3Q14. Developers that launched new condominium (condo) projects in 3Q14 like Supalai (SPALI TB, NEUTRAL, TP: THB27.00), AP Thailand (AP TB, NEUTRAL, TP: THB8.00), Land & Houses (LH TB, BUY, TP: THB12.50) and Pruksa Real Estate (Pruksa) (PS TB, BUY, TP: THB43.00) recorded strong y-o-y presales growth. Companies with no new launches in 3Q14 like LPN Development (LPN) (LPN TB, BUY, TP: THB27.00) and Sansiri (SIRI TB, TRADING BUY, TP: THB2.34) booked presale declines. Quarterly new launches may peak in 4Q14 as LPN and Sansiri resume their launches valued at THB20bn-25bn in total. We think 2014 sectoral presales could contract by 10% y-o-y. Next year, we expect double-digit presales growth to resume. Sectoral 5-year presales CAGR (2009-2013) was at 20%. Top Buys are Quality Houses (QH TB, BUY, TP: THB5.50), Pruksa and LPN – the top three large-cap developers with the highest 2015F earnings growth. Ananda Development (ANAN TB, BUY, TP: THB3.70) is our small-cap Top Pick. Last Thursday, the Monetary Authority of Singapore (MAS) published a consultation paper to strengthen the S-REIT market. The key changes are: i) the increase in the development limit to 25% of the deposited property (from 10%), and ii) the increase in the aggregate leverage limit to 45% from 35% (single-tier limit without a credit rating requirement) as well as removing the option to leverage up to 60% by obtaining a credit rating. We think there are more pros than cons to the proposed changes. This would incentivise REITs with ageing properties to carry out redevelopment works of their own without assistance from their sponsors. Examples include: i) CapitaCommercial Trust (CCT SP, BUY TP: SGD1.83)’s Golden Shoe Car Park, and ii) CapitaMall Trust (CT SP, BUY TP: SGD2.30)’s Funan Digital Mall and Plaza Singapura. Entities contemplating listing or were listed as business trusts may now find the REIT structure more favourable. However, higher development and gearing limits imply increased risk, and some REITs may become more like developers. This, in turn, may turn away some "safe haven" investors such as insurance and pension funds. Malaysia’s 2015 Budget was well balanced, combining commitments for greater fiscal prudence but mindful of higher costs of living for the people. Important elements include the implementation of the goods and services tax (GST) in April 2015 and a commitment to a petroleum subsidy mechanism. The property and sin sectors were unscathed, while infrastructure projects were strongly featured. The budget mentioned seven large-scale infrastructure projects with a >MYR48bn value. Notably, these include MRT Line 2 and LRT Line 3 (to be implemented in 2015) and the MYR27bn PanBorneo Highway. While these projects will have long gestation periods, it reaffirms our expectation of a strong momentum of construction activity. Preferred sectors include construction, basic materials, technology and property. Some of our Top Picks include Gamuda (GAM MK, BUY, TP: MYR5.61), SapuraKencana Petroleum (SAKP MK, BUY, TP: MYR5.33), Malaysia Airports (MAHB MK, BUY, TP: MYR8.51), Unisem (UNI MK, BUY, TP: MYR2.16) and Press Metal (PRESS MK, BUY, TP: MYR 8.30). Powered by Enhanced Datasystems’ EFATM Platform 3 Company Update, 14 October 2014 OldTown (OTB MK) Buy (Maintained) Consumer Cyclical - Retail Market Cap: USD234m Target Price: Price: MYR2.15 MYR1.71 Macro Risks Sowing The Seeds Of Long-Term Growth Growth Value OldTown (OTB MK) Relative to FTSE Bursa Malaysia KLCI Index (RHS) 2.30 108 2.20 104 2.10 99 2.00 95 1.90 91 1.80 87 1.70 82 1.60 4 4 3 3 2 2 1 1 78 0 0 . 2 0 0 OldTown’s share price has corrected >20% from its high of MYR2.22 in . 0 the past three months. Although we expect growth to remain muted for 0 the remaining three quarters after its weak 1QFY15 performance, we 0 believe its growth momentum will gain pace thereafter. Maintain BUY with a revised TP of MYR2.15 (from MYR2.30), implying a 25.7% upside. The stock is currently trading at an undemanding FY16 P/E of 12.8x. Aug-14 Jun-14 Apr-14 Feb-14 Dec-13 Oct-13 Vol m Price Close Source: Bloomberg Avg Turnover (MYR/USD) Cons. Upside (%) Upside (%) 52-wk Price low/high (MYR) Free float (%) Share outstanding (m) Shareholders (%) Oldtown International Franklin Resources Mawer Investment Management 1.28m/0.40m 29.2 25.7 1.71 - 2.26 49 447 42.8 6.4 6.7 Recent share price retracement. OldTown’s share price has corrected by >20% from its high of MYR2.22 in the past three months. We believe the retracement was due to a combination of: i) weak 1QFY15 (Mar) results, ii) the weak performance of its food and beverage (F&B) arm, which reflects the current challenging operating environment, and ii) slower-than-expected growth in its key earnings catalyst, ie its fastmoving consumer goods (FMCG) arm. Counting on its FMCG arm. Moving forward, we expect growth from its F&B arm to remain soft amid stiff competition and consumers’ cautious discretionary spending. Its FMCG arm, on the other hand, should recover and underpin growth ahead. The weak performance of its FMCG arm in 1QFY15 was due to seasonal factors as well as higher-thanexpected selling and distribution spending. We note that sales have picked up in the subsequent quarters after the delay in promotions of its FMCG products in China in 1QFY15. Hence, we expect earnings from its FMCG arm to normalise in the second half. In the medium to long term, we expect earnings for its FMCG arm to grow by double digits, driven by: i) growth in local sales from improving consumer sentiment, and ii) growth in its export markets, particularly in Asean. Risks. Key risks include: i) weaker-than-expected consumer sentiment, ii) a change in consumer preference, and iii) rising raw material prices. Maintain BUY with a revised TP of MYR2.15. We trim our TP to MYR2.15 (from MYR2.30), based on a revised FY16 P/E of 16x (from 18x) to reflect the challenging operating environment for its F&B division. However, we remain optimistic that its FMCG arm should start to reap the fruits from an expanding regional distribution network next year. The stock is currently trading at an undemanding FY16 P/E of 12.8x relative to its peer target valuations of 19-22x. Forecasts and Valuations Share Performance (%) YTD 1m 3m 6m 12m Absolute (17.8) (11.4) (21.2) (14.1) (16.8) Relative (14.7) (8.9) (17.2) (11.7) (18.1) Shariah compliant Fong Kah Yan +603 9207 7668 fong.kah.yan@rhbgroup.com 2 . 2 0 . 2 Mar-12 Mar-13 Mar-14 Mar-15F 299 337 382 417 484 Reported net profit (MYRm) 41.4 44.4 49.0 49.2 59.9 Recurring net profit (MYRm) 34.5 44.4 49.0 49.2 59.9 Recurring net profit growth (%) 23.2 28.8 10.2 0.5 21.7 Recurring EPS (MYR) 0.10 0.12 0.11 0.11 0.13 DPS (MYR) 0.06 0.07 0.06 0.06 0.07 Recurring P/E (x) 16.9 14.0 15.8 15.5 12.8 P/B (x) 2.46 2.04 2.36 2.24 2.06 P/CF (x) 12.7 11.0 11.6 9.6 8.7 3.7 4.2 3.5 3.2 3.9 7.72 5.86 8.27 7.19 5.57 24.8 17.0 15.4 14.7 16.8 Total turnover (MYRm) Dividend Yield (%) EV/EBITDA (x) Return on average equity (%) Net debt to equity (%) Our vs consensus EPS (adjusted) (%) Mar-16F net cash net cash net cash net cash net cash (7.5) 1.5 Source: Company data, RHB See important disclosures at the end of this report Powered by EFATM Platform 4 RHB Guide to Investment Ratings Buy: Share price may exceed 10% over the next 12 months Trading Buy: Share price may exceed 15% over the next 3 months, however longer-term outlook remains uncertain Neutral: Share price may fall within the range of +/- 10% over the next 12 months Take Profit: Target price has been attained. Look to accumulate at lower levels Sell: Share price may fall by more than 10% over the next 12 months Not Rated: Stock is not within regular research coverage Disclosure & Disclaimer All research is based on material compiled from data considered to be reliable at the time of writing, but RHB does not make any representation or warranty, express or implied, as to its accuracy, completeness or correctness. No part of this report is to be construed as an offer or solicitation of an offer to transact any securities or financial instruments whether referred to herein or otherwise. This report is general in nature and has been prepared for information purposes only. It is intended for circulation to the clients of RHB and its related companies. Any recommendation contained in this report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. This report is for the information of addressees only and is not to be taken in substitution for the exercise of judgment by addressees, who should obtain separate legal or financial advice to independently evaluate the particular investments and strategies. This report may further consist of, whether in whole or in part, summaries, research, compilations, extracts or analysis that has been prepared by RHB’s strategic, joint venture and/or business partners. No representation or warranty (express or implied) is given as to the accuracy or completeness of such information and accordingly investors should make their own informed decisions before relying on the same. RHB, its affiliates and related companies, their respective directors, associates, connected parties and/or employees may own or have positions in securities of the company(ies) covered in this research report or any securities related thereto, and may from time to time add to, or dispose off, or may be materially interested in any such securities. Further, RHB, its affiliates and related companies do and seek to do business with the company(ies) covered in this research report and may from time to time act as market maker or have assumed an underwriting commitment in securities of such company(ies), may sell them or buy them from customers on a principal basis and may also perform or seek to perform significant investment banking, advisory or underwriting services for or relating to such company(ies), as well as solicit such investment, advisory or other services from any entity mentioned in this research report. RHB and its employees and/or agents do not accept any liability, be it directly, indirectly or consequential losses, loss of profits or damages that may arise from any reliance based on this report or further communication given in relation to this report, including where such losses, loss of profits or damages are alleged to have arisen due to the contents of such report or communication being perceived as defamatory in nature. The term “RHB” shall denote where applicable, the relevant entity distributing the report in the particular jurisdiction mentioned specifically herein below and shall refer to RHB Research Institute Sdn Bhd, its holding company, affiliates, subsidiaries and related companies. All Rights Reserved. This report is for the use of intended recipients only and may not be reproduced, distributed or published for any purpose without prior consent of RHB and RHB accepts no liability whatsoever for the actions of third parties in this respect. Malaysia This report is published and distributed in Malaysia by RHB Research Institute Sdn Bhd (233327-M), Level 11, Tower One, RHB Centre, Jalan Tun Razak, 50400 Kuala Lumpur, a wholly-owned subsidiary of RHB Investment Bank Berhad (RHBIB), which in turn is a wholly-owned subsidiary of RHB Capital Berhad. Singapore This report is published and distributed in Singapore by DMG & Partners Research Pte Ltd (Reg. No. 200808705N), a wholly-owned subsidiary of DMG & Partners Securities Pte Ltd, a joint venture between Deutsche Asia Pacific Holdings Pte Ltd (a subsidiary of Deutsche Bank Group) and OSK Investment Bank Berhad, Malaysia which have since merged into RHB Investment Bank Berhad (the merged entity is referred to as “RHBIB”, which in turn is a whollyowned subsidiary of RHB Capital Berhad). DMG & Partners Securities Pte Ltd is a Member of the Singapore Exchange Securities Trading Limited. DMG & Partners Securities Pte Ltd may have received compensation from the company covered in this report for its corporate finance or its dealing activities; this report is therefore classified as a non-independent report. As of 28 13 October 2014May 2014, DMG & Partners Securities Pte Ltd and its subsidiaries, including DMG & Partners Research Pte Ltd do not have proprietary positions in the securities covered in this report, except for: a) -As of 28 13 October 2014May 2014, none of the analysts who covered the securities in this report has an interest in such securities, except for: a) -Special Distribution by RHB Where the research report is produced by an RHB entity (excluding DMG & Partners Research Pte Ltd) and distributed in Singapore, it is only distributed to "Institutional Investors", "Expert Investors" or "Accredited Investors" as defined in the Securities and Futures Act, CAP. 289 of Singapore. If you are not an "Institutional Investor", "Expert Investor" or "Accredited Investor", this research report is not intended for you and you should disregard this research report in its entirety. In respect of any matters arising from, or in connection with this research report, you are to contact our Singapore Office, DMG & Partners Securities Pte Ltd Hong Kong This report is published and distributed in Hong Kong by RHB OSK Securities Hong Kong Limited (“RHBSHK”) (formerly known as OSK Securities Hong 5 Kong Limited), a subsidiary of OSK Investment Bank Berhad, Malaysia which have since merged into RHB Investment Bank Berhad (the merged entity is referred to as “RHBIB”), which in turn is a wholly-owned subsidiary of RHB Capital Berhad. RHBSHK, RHBIB and/or other affiliates may beneficially own a total of 1% or more of any class of common equity securities of the subject company. RHBSHK, RHBIB and/or other affiliates may, within the past 12 months, have received compensation and/or within the next 3 months seek to obtain compensation for investment banking services from the subject company. Risk Disclosure Statements The prices of securities fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. Past performance is not a guide to future performance. RHBSHK does not maintain a predetermined schedule for publication of research and will not necessarily update this report Indonesia This report is published and distributed in Indonesia by PT RHB OSK Securities Indonesia (formerly known as PT OSK Nusadana Securities Indonesia), a subsidiary of OSK Investment Bank Berhad, Malaysia, which have since merged into RHB Investment Bank Berhad, which in turn is a wholly-owned subsidiary of RHB Capital Berhad. Thailand This report is published and distributed in Thailand by RHB OSK Securities (Thailand) PCL (formerly known as OSK Securities (Thailand) PCL), a subsidiary of OSK Investment Bank Berhad, Malaysia, which have since merged into RHB Investment Bank Berhad, which in turn is a wholly-owned subsidiary of RHB Capital Berhad. Other Jurisdictions In any other jurisdictions, this report is intended to be distributed to qualified, accredited and professional investors, in compliance with the law and regulations of the jurisdictions. DMG & Partners Research Guide to Investment Ratings Kuala Lumpur Hong Kong Singapore Malaysia Tel : +(60) 3 9280 2185 Fax : +(60) 3 9284 8693 19 Des Voeux Road Central, Hong Kong Tel : +(852) 2525 1118 Fax : +(852) 2810 0908 Tel : +(65) 6533 1818 Fax : +(65) 6532 6211 Buy: Share price may exceed 10% over the next 12 months Trading Buy:Malaysia Share price may exceed 15% over theRHB nextOSK 3 months, however longer-term outlook remains uncertain Research Office Securities Hong Kong Ltd. (formerly known DMG & Partners Neutral: Share mayInstitute fall within months as 12 OSK Securities Securities Pte. Ltd. RHB price Research Sdn the Bhdrange of +/- 10% over the next Take Profit: Target price has been attained. Look to accumulate at lower levels Hong Kong Ltd.) Level 11, Tower One, RHB Centre 10 Collyer Quay Sell: Share price may more than 10% over the next 12 months Jalanfall TunbyRazak 12th Floor #09-08 Ocean Financial Centre Lumpur World-Wide House Singapore 049315 Not Rated: Stock isKuala not within regular research coverage DISCLAIMERS Phnom Penh This research is issuedJakarta by DMG & Partners Research Pte Ltd and it is forShanghai general distribution only. It does not have any regard to the specific investment objectives, financial situation and particular needs of any specific recipient of this research report. You should independently evaluate particular PT RHB OSK and Securities Indonesia (formerlyfinancial known asadviser RHB OSK (China) Advisory Ltd. into any RHBtransaction OSK Indochina Securities Limited (formerly investments consult an independent before makingInvestment any investments or Co. entering in relation to any securities or PT OSKmentioned Nusadana in this report. (formerly known as OSK (China) Investment known as OSK Indochina Securities Limited) investment instruments Securities Indonesia) Plaza CIMB Niaga Advisory Co. Ltd.) Suite 4005, CITIC Square No. 1-3, Street 271 Sangkat Toeuk Thla, Khan Sen Sok Tel : +(6221) 2598 6888 Tel : +(8621) 6288 9611 Fax: +(855) 23 969 171 The information contained herein has been obtained from sources 1168 we believed to be reliable but we do not make any representation or warranty nor 14th Floor Nanjing West Road Phnom Penh accept any responsibility or liability as to its accuracy, completeness orShanghai correctness. are subject to change Jl. Jend. Sudirman Kav.25 20041Opinions and views expressed in this report Cambodia without notice. Jakarta Selatan 12920, Indonesia China Tel: +(855) 23 969 161 Fax : +(6221) 2598or6777 Faxof: +(8621) 6288 9633or sell any securities. This report does not constitute form part of any offer or solicitation any offer to buy Bangkok DMG & Partners Research Pte Ltd is a wholly-owned subsidiary of DMG & Partners Securities Pte Ltd, a joint venture between OSK Investment Bank Berhad, Malaysia which have since merged into RHBRHB Investment Bank Berhad (the merged entity is referred to as “RHBIB” which in turn is a whollyOSK Securities (Thailand) PCL (formerly known owned subsidiary of RHB Capital Berhad) and Deutsche Asiaas Pacific Holdings Pte Ltd (a PCL) subsidiary of Deutsche Bank Group). DMG & Partners Securities OSK Securities (Thailand) Pte Ltd is a Member of the Singapore Exchange Securities Trading Limited. 10th Floor, Sathorn Square Office Tower 98, North Sathorn Road,Silom Bangkok 10500 DMG & Partners Securities Pte Ltd and their associates, directors,Bangrak, and/or employees may have positions in, and may effect transactions in the securities Thailand covered in the report, and may also perform or seek to perform broking and other corporate finance related services for the corporations whose securities Tel: +(66) 2 862report. 9999 are covered in the report. This report is therefore classified as a non-independent Fax : +(66) 2 108 0999 As of 13 October 2014, DMG & Partners Securities Pte Ltd and its subsidiaries, including DMG & Partners Research Pte Ltd, do not have proprietary positions in the subject companies, except for: a) As of 13 October 2014, none of the analysts who covered the stock in this report has an interest in the subject companies covered in this report, except for: a) DMG & Partners Research Pte. Ltd. (Reg. No. 200808705N) 6
© Copyright 2024